Related Experiment Videos
Revision of HIV center medical staging scale
N L McCain1, D E Lyon, R Higginson
1School of Nursing, Virginia Commonwealth University, Richmond 23298, USA. nmccain@hsc.vcu.edu
Insights
This study introduces the revised HIV Center Medical Staging Scale (rHCMSS), an ordinal scale to better measure HIV progression. It offers a more detailed assessment than the nominal CDC system for clinical and research use.
Area of Science:
- Immunology
- Infectious Diseases
- Medical Informatics
Background:
- HIV symptomatology is a key indicator of immune function and disease progression.
- The current Center for Disease Control (CDC) classification system offers nominal-level measurement, potentially limiting clinical and research applications.
- There is a need for a more sensitive scale to track HIV disease advancement.
Purpose of the Study:
- To describe the revision and validation of the HIV Center Medical Staging Scale (rHCMSS).
- To introduce an ordinal-level scale for measuring HIV-disease symptomatology and immunological decline.
- To provide a tool for more comprehensive HIV progression assessment.
Main Methods:
- Revision and validation of the HIV Center Medical Staging Scale (rHCMSS).
- Development of an ordinal-level physical illness scale.
- Assessment of scale's utility in conjunction with CDC classification, T-lymphocyte counts, and viral load data.
Main Results:
- The revised HIV Center Medical Staging Scale (rHCMSS) was validated as an ordinal-level scale.
- The rHCMSS provides a means to independently measure HIV-disease symptomatology progression.
- The scale complements existing measures for a comprehensive HIV assessment.
Conclusions:
- The rHCMSS offers improved measurement of HIV disease progression compared to nominal scales.
- Concurrent use of rHCMSS, CDC system, T-lymphocyte, and viral load data enhances HIV assessment.
- The validated rHCMSS is valuable for both clinical and research purposes in managing HIV.
Abstract:
HIV-related symptomatology represents both an indirect measure of immune functioning and a clinically significant indicator of disease progression. The most widely used classification system for HIV-related symptomatology is the Center for Disease Control (CDC) system. Although the CDC scale has widely recognized clinical utility, it provides only nominal-level measurement, which may be problematic for both clinicians and researchers. This article describes the revision and validation of the HIV Center Medical Staging Scale (rHCMSS), and ordinal-level physical illness scale that provides a means of independently measuring the progression of HIV-disease symptomatology and immunological decline. Concurrent use of the rHCMSS, the CDC classification system, and T-lymphocyte and viral load data will provide a more comprehensive indication of HIV-disease progression for clinical and research purposes.